Sign Out
UserName
Profession Email
Profession Email
|
Contraindications
Prostatic or breast carcinoma (male); nephrosis, porphyria; infants, pregnancy and lactation.
|
|
Special Precautions
Monitor diabetic patients carefully. Conditions influenced by oedema (e.g. CV disease, migraine, seizure disorder, renal impairment). Hepatic impairment. Elderly. Discontinue if signs of virilisation in women occur. Monitor skeletal maturation in children.
|
|
Adverse Reactions
Male: Postpubertal: Acne, gynaecomastia, bladder irritability, priapism, insomnia, chills, decreased libido, hepatic dysfunction, nausea, diarrhoea, prostatic hyperplasia. Prepubertal: Acne, virilism, chills, insomnia, hyperpigmentation, diarrhoea, nausea. Female: Virilism, hypercalcaemia, nausea, diarrhoea, chills, insomnia, iron deficiency anaemia, hepatic dysfunction.
|
|
Drug Interactions
May increase effects of oral anticoagulants, insulin, oral antidiabetic agents, adrenal steroid, adrenocorticotropic hormone (ACTH).
|
|
CIMS Class
|
|
ATC Classification
A14AB01 - nandrolone ; Belongs to the class of estren derivative anabolic steroids used as systemic anabolic agents.
S01XA11 - nandrolone ; Belongs to the class of other ophthalmologicals. |
